The market for DDR inhibitors is emerging, and is expected to grow significantly in the coming years 📈 To learn more about DDR Inhibitors, check out our recent blog!
Our new blog post dives into DDR Inhibitors, a class of pharmaceuticals used to treat certain types of cancers, and why investors should be interested. 🧬
redthread.ventures/blog/new-…
We have published several press releases in the past few months, including presentation and financial information.
Interested? To read more, check out our website!
lnkd.in/eE_aSXqk
Taking it back to when our president Mads Daugaard sat down with the Red Thread Ventures team to talk a little more about our 3 research programs. Check out the episode "Biotech Innovation with Mads Daugaard" to learn more! 👏🧬
Very excited to announce our investment in @LevrFinance $1,000,000 pre-seed round!
Levr is a Vancouver based fintech software company transforming the way businesses access and manage loans. 💻 🏦💰
medium.com/@weave.vc/announc…
Rakovina will be presenting at the 6th annual DDR Inhibitors Summit in Boston on January 24th - 26th! Tune in on January 24th at 9:00am EST for a seminar from our President, Mads Daugaard 👏 🧬
PEOPLE.
Feb 16th. In Vancouver.
Me, @ShaanVP, @awilkinson and maybe some special guests.
Live meetup, hang out, and maybe some talking.
COME. Free. Deal of the century.
Enter email there and we'll send you final details when they're lined up.
fl6myeqzzm6.typeform.com/and…
In case you missed it, we recently posted a new blog: "Welcoming a New Era of Cancer Therapy"!
Check it out to learn more about the future of #biotech and #pharma, and about some of the amazing work done by @rakovina_rkv ! 👏🧬
redthread.ventures/blog/welc…